Cuadra, Merliza A.
HRN: 27-62-92 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/13/2025
AMPICILLIN 1GM (VIAL)
08/13/2025
08/16/2025
IV
2g
Q6
PPROM
Checking Initial Appropriateness
08/14/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/14/2025
08/15/2025
IVT
500mg
Q8
S/p CS
Checking Initial Appropriateness
08/14/2025
CO-AMOXICLAV 625MG (TAB)
08/14/2025
08/20/2025
PO
625mg
Bid
Cs
Checking Initial Appropriateness
08/14/2025
METRONIDAZOLE 500MG (TAB)
08/14/2025
08/20/2025
PO
500mg
TID
Cs
Checking Initial Appropriateness